The antiviral medication remdesivir has played a controversial role in the COVID-19 treatment protocols used by hospitals that many families allege resulted in the death of their loved ones. Among the ...

Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data ...

When the COVID-19 pandemic hit, one of the first medicines doctors turned to was remdesivir, part of a family of medicines called nucleoside analogues that are also used to treat HIV, hepatitis and ...

Remdesivir is currently the only antiviral drug approved in the U.S. for treating COVID-19 patients. In a paper published this week in Cell Reports, researchers from The University of Texas at Austin, ...

As SARS-CoV-2 variants continue to circulate and the severely ill seek medical care, physicians require a quantitative means to measure virus growth in order to assess treatment efficacy. Because SARS ...

A new study provides important insights into the pharmacokinetics and safety of intravenous remdesivir in treating the SARS-CoV-2 coronavirus in pregnant women. Remdesivir is an antiviral medication ...

Researchers have finally published the data that led the federal government to recommend the use of the antiviral drug remdesivir in very ill coronavirus patients, and they say the drug alone will not ...

Hours after revoking its emergency use authorization (EUA) for hydroxychloroquine and chloroquine to treat coronavirus disease (COVID-19), the US Food and Drug Administration (FDA) is now warning that ...

Dr. Roger Klein, Former Adviser to the FDA & CDC, joins Yahoo Finance’s Seana Smith to discuss the latest developments for a coronavirus vaccine as global cases surpass 4 million, according to John ...

In a groundbreaking decision, a Michigan judge ruled on Aug. 8 that a drug manufacturer and hospital are not protected by the Public Readiness and Emergency Preparedness (PREP) Act in the case of a ...

The United States now has a highly anticipated price tag for the antiviral drug remdesivir. Gilead Sciences, the company that makes the Covid-19 drug, announced in an open letter on Monday morning ...